[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632354":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":34,"centralContacts":43,"locations":49,"responsibleParty":400,"collaborators":34,"id":402,"slug":403,"hasResults":404,"nctId":405,"briefTitle":406,"officialTitle":407,"acronym":34,"eligibilityCriteria":408,"healthyVolunteers":404,"sex":409,"minAge":410,"maxAge":34,"enrollmentInfo":411,"targetDuration":34,"studyType":414,"phases":415,"briefSummary":417,"conditions":418,"keywords":34,"overallStatus":420,"whyStopped":34,"lastUpdateSubmitDate":421,"lastUpdatePostDateStruct":422,"startDateStruct":425,"completionDateStruct":427,"leadSponsor":429,"locationsCount":430},{"fullName":5,"class":6},"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","INDUSTRY",[8,15,21,25],{"label":9,"type":10,"description":11,"interventionNames":12},"Low-dose TQD3524 + Meropenem for injection","EXPERIMENTAL","TQD3524: 2.5mg\u002Fkg, q12h, intravenous drip, for a duration of 7 to 14 days, with a maximum of 21 days TQD3524 : 70mg, q12h, nebulized inhalation, for a duration of 7 to 14 days, with a maximum of 21 days Meropenem for injection: 2g, q8h,intravenous drip, for a duration of 7 to 14 days, with a maximum of 21 days",[13,14],"Drug: TQD3524","Drug: Meropenem for injection",{"label":16,"type":17,"description":18,"interventionNames":19},"Colistimethate Sodium for Injection + Meropenem for injection (Low-dose control)","ACTIVE_COMPARATOR","Colistimethate Sodium for Injection: 2.5mg\u002Fkg, q12h, intravenous drip, for a duration of 7 to 14 days, with a maximum of 21 days Colistimethate Sodium for Injection: 70mg, q12h, nebulized inhalation, for a duration of 7 to 14 days, with a maximum of 21 days Meropenem for injection: 2g, q8h,intravenous drip, for a duration of 7 to 14 days, with a maximum of 21 days",[14,20],"Drug: Colistimethate Sodium for Injection",{"label":22,"type":10,"description":23,"interventionNames":24},"High-dose TQD3524 + Meropenem for injection","TQD3524: 3.75mg\u002Fkg, q12h, intravenous drip, for a duration of 7 to 14 days, with a maximum of 21 days TQD3524 : 70mg, q12h, nebulized inhalation, for a duration of 7 to 14 days, with a maximum of 21 days Meropenem for injection: 2g, q8h,intravenous drip, for a duration of 7 to 14 days, with a maximum of 21 days",[13,14],{"label":26,"type":17,"description":18,"interventionNames":27},"Colistimethate Sodium for Injection + Meropenem for injection (High-dose control)",[14,20],[29,35,39],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","TQD3524","After entering the body, TQD3524 can be hydrolyzed into polymyxin E2 and its derivatives, exerting bactericidal effects .",[22,9],null,{"type":30,"name":36,"description":37,"armGroupLabels":38,"otherNames":34},"Meropenem for injection","Meropenem for injection is a β-lactam.",[26,16,22,9],{"type":30,"name":40,"description":41,"armGroupLabels":42,"otherNames":34},"Colistimethate Sodium for Injection","Colistimethate Sodium for Injection is a prodrug of polymyxin E. After entering the body, polymyxin E mesylate is hydrolyzed to polymyxin E (colistin), which exerts bactericidal activity.",[26,16],[44],{"name":45,"role":46,"phone":47,"phoneExt":34,"email":48},"Yanbin Liu, Doctor","CONTACT","18980601983","dr_liuyanbin@foxmail.com",[50,68,83,98,113,127,144,158,173,188,199,210,220,235,246,261,276,291,297,311,326,337,352,363,374,389],{"facility":51,"status":34,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"The First Affiliated Hospital of Bengbu Medical College","Bengbu","Anhui","233000","China","CN",{"type":58,"coordinates":59},"Point",[60,61],117.36083,32.94083,{"lat":61,"lon":60},[64],{"name":65,"role":46,"phone":66,"phoneExt":34,"email":67},"Shibing Zhao, Master","13855212871","zhaoshibing523@163.com",{"facility":69,"status":34,"city":70,"state":71,"zip":72,"country":55,"countryCode":56,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Beijing Tsinghua Changgung Hospital","Beijing","Beijing Municipality","102200",{"type":58,"coordinates":74},[75,76],116.39723,39.9075,{"lat":76,"lon":75},[79],{"name":80,"role":46,"phone":81,"phoneExt":34,"email":82},"Xuzhu Ma, Doctor","13910204904","mxz@btch.edu.cn",{"facility":84,"status":34,"city":85,"state":86,"zip":87,"country":55,"countryCode":56,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"The First Affiliated Hospital of Chongqing Medical University","Chongqing","Chongqing Municipality","400016",{"type":58,"coordinates":89},[90,91],106.55771,29.56026,{"lat":91,"lon":90},[94],{"name":95,"role":46,"phone":96,"phoneExt":34,"email":97},"Xiaoli Han, Master","13271943396","hxl093@163.com",{"facility":99,"status":34,"city":100,"state":101,"zip":102,"country":55,"countryCode":56,"cosmosGeoPoint":103,"geoPoint":107,"contacts":108},"Foshan Nanhai District People's Hospital","Foshan","Guangdong","528200",{"type":58,"coordinates":104},[105,106],113.13148,23.02677,{"lat":106,"lon":105},[109],{"name":110,"role":46,"phone":111,"phoneExt":34,"email":112},"Zongmian Zhang, Bachelor","13590550630","mian74@qq.com",{"facility":114,"status":34,"city":115,"state":101,"zip":116,"country":55,"countryCode":56,"cosmosGeoPoint":117,"geoPoint":121,"contacts":122},"The First Clinical College of Guangzhou Medical University","Guangzhou","510120",{"type":58,"coordinates":118},[119,120],113.25,23.11667,{"lat":120,"lon":119},[123],{"name":124,"role":46,"phone":125,"phoneExt":34,"email":126},"Chao Zhuo, Doctor","18928868397","chaosheep@sina.com",{"facility":128,"status":34,"city":129,"state":101,"zip":130,"country":55,"countryCode":56,"cosmosGeoPoint":131,"geoPoint":135,"contacts":136},"Peking University Shenzhen Hospital","Shenzhen","518036",{"type":58,"coordinates":132},[133,134],114.0683,22.54554,{"lat":134,"lon":133},[137,141],{"name":138,"role":46,"phone":139,"phoneExt":34,"email":140},"Lei Huang, Doctor","13510331883","hl0248@outlook.com",{"name":142,"role":46,"phone":143,"phoneExt":34,"email":140},"Ruilin Sun, Doctor","13825167802",{"facility":145,"status":34,"city":146,"state":101,"zip":147,"country":55,"countryCode":56,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"The Fifth Affiliated Hospital, Sun Yat-sen University","Zhuhai","519000",{"type":58,"coordinates":149},[150,151],113.56778,22.27694,{"lat":151,"lon":150},[154],{"name":155,"role":46,"phone":156,"phoneExt":34,"email":157},"Liu Xi, Doctor","15992670630","liuxi26@mail.sysu.edu.cn",{"facility":159,"status":34,"city":160,"state":161,"zip":162,"country":55,"countryCode":56,"cosmosGeoPoint":163,"geoPoint":167,"contacts":168},"The Second Hospital Of Hebei Medical University","Shijiazhuang","Hebei","050000",{"type":58,"coordinates":164},[165,166],114.47861,38.04139,{"lat":166,"lon":165},[169],{"name":170,"role":46,"phone":171,"phoneExt":34,"email":172},"Zhigang Cai, Doctor","18233106552","zhigang_cai@163.com",{"facility":174,"status":34,"city":175,"state":176,"zip":177,"country":55,"countryCode":56,"cosmosGeoPoint":178,"geoPoint":182,"contacts":183},"Henan Provincial People's Hospital","Zhengzhou","Henan","450003",{"type":58,"coordinates":179},[180,181],113.64861,34.75778,{"lat":181,"lon":180},[184],{"name":185,"role":46,"phone":186,"phoneExt":34,"email":187},"Yi Kang, Doctor","13938553839","13938553839@163.com",{"facility":189,"status":34,"city":175,"state":176,"zip":190,"country":55,"countryCode":56,"cosmosGeoPoint":191,"geoPoint":193,"contacts":194},"Zhengzhou Central Hospital","450007",{"type":58,"coordinates":192},[180,181],{"lat":181,"lon":180},[195],{"name":196,"role":46,"phone":197,"phoneExt":34,"email":198},"Yanqiu Gao, Master","13673999263","13673999263@163.com",{"facility":200,"status":34,"city":175,"state":176,"zip":201,"country":55,"countryCode":56,"cosmosGeoPoint":202,"geoPoint":204,"contacts":205},"The Fifth Affiliated Hospital of Zhengzhou University","450052",{"type":58,"coordinates":203},[180,181],{"lat":181,"lon":180},[206],{"name":207,"role":46,"phone":208,"phoneExt":34,"email":209},"Yonghai Feng, Master","13623712087","13623712087@163.com",{"facility":211,"status":34,"city":175,"state":176,"zip":201,"country":55,"countryCode":56,"cosmosGeoPoint":212,"geoPoint":214,"contacts":215},"The Second Affiliated Hospital of Zhengzhou University",{"type":58,"coordinates":213},[180,181],{"lat":181,"lon":180},[216],{"name":217,"role":46,"phone":218,"phoneExt":34,"email":219},"Xiaojun Liu, Bachelor","13939199151","drliuxiaojun@163.com",{"facility":221,"status":34,"city":222,"state":223,"zip":224,"country":55,"countryCode":56,"cosmosGeoPoint":225,"geoPoint":229,"contacts":230},"Xiangya Hospital of Central South University","Changsha","Hunan","410000",{"type":58,"coordinates":226},[227,228],112.97087,28.19874,{"lat":228,"lon":227},[231],{"name":232,"role":46,"phone":233,"phoneExt":34,"email":234},"Yuanyuan Li, Doctor","13975806790","Leeround@163.com",{"facility":236,"status":34,"city":222,"state":223,"zip":237,"country":55,"countryCode":56,"cosmosGeoPoint":238,"geoPoint":240,"contacts":241},"People's Hospital of Hunan Province","410005",{"type":58,"coordinates":239},[227,228],{"lat":228,"lon":227},[242],{"name":243,"role":46,"phone":244,"phoneExt":34,"email":245},"Yan Cao, Doctor","15116485862","13383771@qq.com",{"facility":247,"status":34,"city":248,"state":249,"zip":250,"country":55,"countryCode":56,"cosmosGeoPoint":251,"geoPoint":255,"contacts":256},"Northern Jiangsu People's Hospital","Yangzhou","Jiangsu","225000",{"type":58,"coordinates":252},[253,254],119.43583,32.39722,{"lat":254,"lon":253},[257],{"name":258,"role":46,"phone":259,"phoneExt":34,"email":260},"Lingfeng Min, Doctor","18051061783","minlingfeng@126.com",{"facility":262,"status":34,"city":263,"state":264,"zip":265,"country":55,"countryCode":56,"cosmosGeoPoint":266,"geoPoint":270,"contacts":271},"First Affiliated Hospital of Gannan Medical University","Ganzhou","Jiangxi","341000",{"type":58,"coordinates":267},[268,269],114.9326,25.84664,{"lat":269,"lon":268},[272],{"name":273,"role":46,"phone":274,"phoneExt":34,"email":275},"Shaochun Yang, Master","13766399775","yangshch680709@hotmail.com",{"facility":277,"status":34,"city":278,"state":279,"zip":280,"country":55,"countryCode":56,"cosmosGeoPoint":281,"geoPoint":285,"contacts":286},"The First Affiliated Hospital of Xi'an Jiao Tong University","Xi'an","Shaanxi","710000",{"type":58,"coordinates":282},[283,284],108.92861,34.25833,{"lat":284,"lon":283},[287],{"name":288,"role":46,"phone":289,"phoneExt":34,"email":290},"YingLi He, Doctor","18991232863","Heyingli2000@163.com",{"facility":292,"status":34,"city":278,"state":279,"zip":293,"country":55,"countryCode":56,"cosmosGeoPoint":294,"geoPoint":296,"contacts":34},"Xi'an Chest Hospital","710100",{"type":58,"coordinates":295},[283,284],{"lat":284,"lon":283},{"facility":298,"status":34,"city":299,"state":279,"zip":300,"country":55,"countryCode":56,"cosmosGeoPoint":301,"geoPoint":305,"contacts":306},"Yan'an University Xianyang Hospital","Xianyang","712000",{"type":58,"coordinates":302},[303,304],108.70261,34.33778,{"lat":304,"lon":303},[307],{"name":308,"role":46,"phone":309,"phoneExt":34,"email":310},"Jianhou Jia, Master","13892007197","jjh20@126.com",{"facility":312,"status":34,"city":313,"state":314,"zip":315,"country":55,"countryCode":56,"cosmosGeoPoint":316,"geoPoint":320,"contacts":321},"Shanghai General Hospital","Shanghai","Shanghai Municipality","200080",{"type":58,"coordinates":317},[318,319],121.45806,31.22222,{"lat":319,"lon":318},[322],{"name":323,"role":46,"phone":324,"phoneExt":34,"email":325},"Min Zhang, Doctor","13482345145","maggie_zhangmin@163.com",{"facility":327,"status":34,"city":313,"state":314,"zip":328,"country":55,"countryCode":56,"cosmosGeoPoint":329,"geoPoint":331,"contacts":332},"Shanghai Pulmonary Hospital","200433",{"type":58,"coordinates":330},[318,319],{"lat":319,"lon":318},[333],{"name":334,"role":46,"phone":335,"phoneExt":34,"email":336},"Haiwen Lu, Doctor","13917110982","haiwen_lu@163.cm",{"facility":338,"status":34,"city":339,"state":340,"zip":341,"country":55,"countryCode":56,"cosmosGeoPoint":342,"geoPoint":346,"contacts":347},"Chengdu Third People's Hospital","Chengdu","Sichuan","610031",{"type":58,"coordinates":343},[344,345],104.06667,30.66667,{"lat":345,"lon":344},[348],{"name":349,"role":46,"phone":350,"phoneExt":34,"email":351},"Guoping Li, Doctor","18982791605","lzlgp@163.com",{"facility":353,"status":34,"city":339,"state":340,"zip":354,"country":55,"countryCode":56,"cosmosGeoPoint":355,"geoPoint":357,"contacts":358},"Nuclear Industry 416 Hospital","610051",{"type":58,"coordinates":356},[344,345],{"lat":345,"lon":344},[359],{"name":360,"role":46,"phone":361,"phoneExt":34,"email":362},"ZhiQiang Xu, Master","13551800077","20744929@qq.com",{"facility":364,"status":34,"city":339,"state":340,"zip":365,"country":55,"countryCode":56,"cosmosGeoPoint":366,"geoPoint":368,"contacts":369},"Sichuan Provincial People's Hospital","610072",{"type":58,"coordinates":367},[344,345],{"lat":345,"lon":344},[370],{"name":371,"role":46,"phone":372,"phoneExt":34,"email":373},"Chun Pan, Doctor","13814009925","panchun1982@gmail.com",{"facility":375,"status":34,"city":376,"state":377,"zip":378,"country":55,"countryCode":56,"cosmosGeoPoint":379,"geoPoint":383,"contacts":384},"Tianjin Medical University General Hospital","Tianjin","Tianjin Municipality","300052",{"type":58,"coordinates":380},[381,382],117.17667,39.14222,{"lat":382,"lon":381},[385],{"name":386,"role":46,"phone":387,"phoneExt":34,"email":388},"Jie Cao, Master","13132088076","jiecao13995@163.com",{"facility":390,"status":34,"city":376,"state":377,"zip":391,"country":55,"countryCode":56,"cosmosGeoPoint":392,"geoPoint":394,"contacts":395},"Tianjin First Central Hospital","300191",{"type":58,"coordinates":393},[381,382],{"lat":382,"lon":381},[396],{"name":397,"role":46,"phone":398,"phoneExt":34,"email":399},"HongMei Gao, Doctor","13072256661","ghm182@163.com",{"type":401,"investigatorFullName":34,"investigatorTitle":34,"investigatorAffiliation":34,"oldNameTitle":34,"oldOrganization":34},"SPONSOR","100632354","phase-2-study-on-the-safety-and-efficacy-of-polymyxin-e2-methanesulfonate-for-injection-in-the-treatment-of-hospital-acquired-bacterial-pneumoniaventilator-associated-bacterial-pneumonia-caused-by-carbapenem-resistant-gram-negative-bacteria-100632354",false,"NCT07512596","Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia\u002FVentilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria","Randomized, Double-blind, Parallel-controlled, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of Polymyxin E2 Mesylate Intravenous Infusion Combined With Nebulized Inhalation in the Treatment of Hospital-acquired Bacterial Pneumonia\u002FVentilator-associated Bacterial Pneumonia Caused by Carbapenem-resistant Gram-negative Bacteria","Inclusion Criteria:\n\n* Age ≥ 18 years old (based on the date of signing the informed consent form);\n* The subject (or their guardian) voluntarily signed the informed consent form；\n* Acute pulmonary infection with hospitalization duration exceeding 48 hours or within 7 days after discharge; or acute pulmonary infection patients who have undergone mechanical ventilation via oral or nasal tracheal intubation for at least 48 hours;\n* Chest imaging examination (X-ray or CT) within 72 hours prior to randomization reveals characteristics of new or worsening pulmonary infiltration;\n* At least one of the following physical signs or laboratory abnormalities: ① fever (temperature ≥38℃); ② hypothermia (temperature ≤35℃); ③ elevated peripheral white blood cell count (WBC ≥10×10\\^9\u002FL); ④ decreased white blood cell count (WBC ≤4.5×10\\^9\u002FL); ⑤ more than 15% of immature neutrophils such as band forms in peripheral blood;\n* At least one of the following clinical symptoms is present: ① new or acute worsening of pulmonary symptoms or signs, such as cough, dyspnea, increased respiratory rate (respiratory rate \\> 25 breaths per minute), expectoration, or the need for mechanical ventilation; ② hypoxemia (arterial blood gas oxygen partial pressure below 60 mmHg at standard atmospheric pressure, or a progressive decrease in the ratio of oxygen partial pressure to inspired oxygen concentration (PaO2\u002FFiO2)); ③ deteriorating oxygenation requiring replacement of ventilation support system to improve oxygenation, or a change in the level of positive end-expiratory pressure support; ④ new respiratory secretions requiring suction;\n* A specific carbapenem-resistant Gram-negative bacterium was cultured from qualified lower respiratory tract specimens within the first five days\u002Fscreening period, with in vitro susceptibility testing confirming resistance to carbapenems；\n* Female subjects without reproductive potential must meet at least one of the following criteria: a) cessation of regular menstruation for at least 12 consecutive months; b) having undergone hysterectomy and\u002For bilateral oophorectomy. Female subjects with reproductive potential must have a negative serum pregnancy test result at the screening visit and agree to use reliable contraception throughout the study period;\n* Male subjects must agree to adopt reliable contraceptive measures throughout the entire study period.\n\nExclusion Criteria:\n\n* Those who currently suffer from epilepsy\u002Fmyasthenia gravis or have a history of seizures (excluding febrile seizures in childhood)\u002Fmyasthenia gravis;\n* Those who are undergoing hemodialysis or peritoneal dialysis;\n* Combined infections with other lung microbiota: viral pneumonia, fungal pneumonia, pulmonary tuberculosis, atypical pathogen infections, etc；\n* Current concurrent infection of other parts\u002Forgans;\n* Patients with concurrent refractory septic shock, who still exhibit persistent hypotension despite adequate fluid resuscitation or vasopressor therapy prior to randomization;\n* Individuals with immune deficiency or compromised immune function, including but not limited to: human immunodeficiency virus infection, hematological malignancies, bone marrow transplantation, immunosuppressive therapy, and systemic corticosteroid treatment (defined as a daily dose equivalent to prednisone ≥20mg and a treatment duration \\>14 days);\n* During the screening period, any of the following laboratory abnormalities is present: aspartate aminotransferase (AST) and\u002For alanine aminotransferase (ALT) levels are more than 5 times the upper limit of normal, or AST and\u002For ALT levels are more than 3 times the upper limit of normal and total bilirubin levels are more than 1.5 times the upper limit of normal, or neutrophil count \\\u003C 1.0×10\\^9\u002FL, or platelet count \\\u003C 60×10\\^9\u002FL; creatinine clearance rate (cLcr) ≤ 50 mL\u002Fmin;\n* Suffering from lung diseases that can interfere with treatment response assessment;\n* Patients with lung abscess, empyema, and mechanical obstructive pneumonia;\n* New York Heart Association (NYHA) class III-IV heart failure;\n* Transplant patients；\n* Patients with an estimated survival time of less than 1 month according to the clinical judgment of the researchers;\n* Those who have allergic reactions to polymyxins or any β-lactams (such as carbapenems, penicillins, monocyclic lactams, cephalosporins);\n* Sbjects requiring \\>2 systemic antimicrobial drugs for the treatment of Gram-negative bacterial infections;\n* Patients with an Acute Physiology and Chronic Health Evaluation II (APACHE II) score greater than 30;\n* Women who are pregnant or breastfeeding;\n* Use potentially effective antibiotics to treat carbapenem resistant gram-negative bacterial infections within 72 hours prior to randomization, and the treatment duration exceeds 24 hours；\n* When the culture results of samples from the first 5 days\u002Fscreening period are available, it is found that the subject has Hospital-Acquired Pneumonia\u002FVentilator-Associated Pneumonia (HAP\u002FVAP) caused by gram-negative bacteria that are expected to have no response to polymyxin drugs;\n* Subjects who have participated in other clinical trials within 30 days prior to the first dose of medication;\n* Other factors determined by the researcher that make the subject unsuitable for participating in this study.","ALL","18 Years",{"count":412,"type":413},48,"ESTIMATED","INTERVENTIONAL",[416],"PHASE2","Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia\u002FVentilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria.",[419],"Hospital-acquired Bacterial Pneumonia\u002FVentilator-associated Bacterial Pneumonia","NOT_YET_RECRUITING","2026-04-01",{"date":423,"type":424},"2026-04-06","ACTUAL",{"date":426,"type":413},"2026-04",{"date":428,"type":413},"2027-07",{"name":5,"class":6},26]